Single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: Final analysis of the DREAMM-2 trial Meeting Abstract
| Authors: | Nooka, A. K.; Cohen, A.; Lee, H. C.; Badros, A. Z.; Suvannasankha, A.; Callander, N.; Abdallah, A. O.; Trudel, S.; Chari, A.; Libby, E.; Chaudhry, M.; Hultcrantz, M.; Kortuem, M.; Richardson, P. G.; Popat, R.; Sborov, D. W.; Hakim, S.; Lewis, E.; Bhushan, B.; Gorsh, B.; Gupta, I.; Opalinska, J.; Lonial, S. |
| Abstract Title: | Single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: Final analysis of the DREAMM-2 trial |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 7301 |
| End Page: | 7303 |
| Language: | English |
| ACCESSION: | WOS:000893230300136 |
| DOI: | 10.1182/blood-2022-164877 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
